GENI vs SGHC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
GENI
SGHC
Investment Advisor Scores
SGHC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GENI | SGHC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 56.8182 | 17.7305 | SGHC |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 30.5% | 18.4% | GENI |
| Earnings Growth | 0.0% | 46.1% | SGHC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.9/100 | 56.1/100 | GENI |
| Profit Margin | -22.3% | 10.5% | SGHC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GENI
MarkupPrice above SMA50, rising 50-day trend (15.9% over 20 days), RSI 57
SGHC
NeutralMixed signals - no dominant trend phase, RSI 45
Fundamentals Snapshot
| Metric | GENI | SGHC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.1 | 15.7 |
| Trailing P/E | — | 29.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.2% |
| Gross Margin | 0.2% | 0.3% |
| Operating Margin | -0.2% | 0.2% |
| EPS | -0.59 | 0.48 |
| Dividend Yield | — | 0.00% |